The activity for the coming months will include:
- the development and trial of new COVID-19 treatments and vaccines
- making UK clinical research delivery easier through more rapid ethics reviews and faster approval processes
- boosting clinical research capacity with more virtual and remote trials
- increasing diversity and participation in research in communities traditionally under-served by research
- digitising the clinical research process to allow researchers to find patients, offer them places in trials, and monitor health outcomes.
Robin Swann, Health Minister, Northern Ireland, said:
“Northern Ireland recognises the value of a UK-wide approach to clinical research and we are committed to participation in the delivery of this vision. We are already fully involved in many of the UK-wide work streams, working in partnership towards collective and compatible solutions to create a clinical research ecosystem which benefits all patients across the UK.”
Close collaborative and partnership working between organisations right across the UK through the Clinical Research Recovery, Resilience and Growth programme - which includes representatives from all UK health departments, the NHS, regulators, the NIHR, medical research charities and industry - will help make the UK one of the best places in the world to conduct cutting-edge clinical research.